Skip to main content
Jyong Biotech Ltd. logo

Jyong Biotech Ltd. — Investor Relations & Filings

Ticker · MENS US Manufacturing
Filings indexed 63 across all filing types
Latest filing 2026-02-06 Foreign Filer Report
Country US United States of America
Listing US MENS

About Jyong Biotech Ltd.

https://jyongbio.com/

Jyong Biotech Ltd. is a science-driven biotechnology company focused on the development and commercialization of plant-derived drugs for urinary system diseases. The company's primary therapeutic areas include benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). Its lead drug candidate, MCS-2, is a botanical formulation that has completed late-stage (Phase III) clinical trials. Leveraging a proprietary research and development platform, Jyong Biotech aims to advance its pipeline of innovative botanical medicines to address unmet medical needs in urology for a global patient population.

Recent filings

Filing Released Lang Actions
6-K Filing
Foreign Filer Report
2026-02-06 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2026-01-09 English
SP 15D2
Regulatory Filings
2025-06-30 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2025-06-18 English
PROSPECTUS
Prospectus
2025-06-18 English
Regulatory Filings 2025
Regulatory Filings
2025-06-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.